Action

Decreases platelet aggregation by reversibly antagonizing the binding of fibrinogen to the glycoprotein IIb/IIIa binding site on platelet surfaces

Therapeutic Effect(s):
Inhibition of platelet aggregation resulting in decreased incidence of new MI, death, or refractory ischemia, reducing the need for repeat urgent cardiac intervention

eptifibatide is a sample topic found in Davis's Drug Guide. All other sections of this record are viewable by clicking on the index in the left column, or by clicking on "Display all Sections" in the "Content Manager".

To find other Davis's Drug Guide topics, please login or purchase a subscription.